Abstract
Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71%. We observed favorable long-term outcomes among MDR-TB patients.
Cite
CITATION STYLE
APA
Shin, S. S., Furin, J. J., Alcántara, F., Bayona, J., Sánchez, E., & Mitnick, C. D. (2006). Long-term follow-up for multidrug-resistant tuberculosis. Emerging Infectious Diseases, 12(4), 687–688. https://doi.org/10.3201/eid1204.041256
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free